{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:48:57Z","timestamp":1791470937882,"version":"4.3.4"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.<\/jats:p>","DOI":"10.1136\/openhrt-2020-001564","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T13:17:07Z","timestamp":1619615827000},"page":"e001564","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Transcatheter mitral valve repair: an overview of current and future devices"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct03142152","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03706833","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02803957","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04375332","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-0278","authenticated-orcid":false,"given":"Ole","family":"De Backer","sequence":"first","affiliation":[{"name":"Cardiology, Rigshospitalet, Kobenhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Wong","sequence":"additional","affiliation":[{"name":"Cardiology, Rigshospitalet, Kobenhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taramasso","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maisano","sequence":"additional","affiliation":[{"name":"Valve Center, Ospedale San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Franzen","sequence":"additional","affiliation":[{"name":"Hirslanden Klinik im Park, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Cardiology, Rigshospitalet, Kobenhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"2025081710351235000_8.1.e001564.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.06.011"},{"key":"2025081710351235000_8.1.e001564.2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.carrev.2020.02.012","article-title":"Long-term survival following transcatheter mitral valve repair: pooled analysis of prospective trials with the Carillon device","volume":"21","author":"Lipiecki","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"2025081710351235000_8.1.e001564.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.012"},{"key":"2025081710351235000_8.1.e001564.4","doi-asserted-by":"crossref","first-page":"W47","DOI":"10.4244\/EIJV11SWA12","article-title":"The ARTO transcatheter mitral valve repair system","volume":"11 Suppl W","author":"Erglis","year":"2015","journal-title":"EuroIntervention"},{"key":"2025081710351235000_8.1.e001564.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.1110"},{"key":"2025081710351235000_8.1.e001564.6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4244\/EIJ-D-20-00484","article-title":"Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial","volume":"16","author":"Worthley","year":"2021","journal-title":"EuroIntervention"},{"key":"2025081710351235000_8.1.e001564.7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/eurheartj\/ehy424","article-title":"Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes","volume":"40","author":"Messika-Zeitoun","year":"2019","journal-title":"Eur Heart J"},{"key":"2025081710351235000_8.1.e001564.8","first-page":"261","article-title":"Transcatheter mitral valve direct Annuloplasty with the millipede iris ring","volume":"8","author":"Rogers","year":"2019","journal-title":"Interv Cardiol Clin"},{"key":"2025081710351235000_8.1.e001564.9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.21037\/acs.2018.10.05","article-title":"Early experience with millipede iris transcatheter mitral annuloplasty","volume":"7","author":"Rogers","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2025081710351235000_8.1.e001564.10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/24748706.2017.1385879","article-title":"Transcatheter annuloplasty for mitral regurgitation with an adjustable semi-rigid complete ring: initial experience with the millipede iris device","volume":"2","author":"Rogers","year":"2018","journal-title":"Structural Heart"},{"key":"2025081710351235000_8.1.e001564.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2004.03.002"},{"key":"2025081710351235000_8.1.e001564.12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq050"},{"key":"2025081710351235000_8.1.e001564.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr101"},{"key":"2025081710351235000_8.1.e001564.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.07.047"},{"key":"2025081710351235000_8.1.e001564.15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10554-011-9872-8","article-title":"Clinical trial experience with the MitraClip catheter based mitral valve repair system","volume":"27","author":"Maisano","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025081710351235000_8.1.e001564.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009355"},{"key":"2025081710351235000_8.1.e001564.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.10.018"},{"key":"2025081710351235000_8.1.e001564.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805374"},{"key":"2025081710351235000_8.1.e001564.19","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/ejhf.1616","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2\u2009years","volume":"21","author":"Iung","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025081710351235000_8.1.e001564.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806640"},{"key":"2025081710351235000_8.1.e001564.21","unstructured":"Mack M , Abraham WT , Lindenfeld J . Three-year outcomes from a randomized trial of transcatheter mitral valve leaflet approximation in patients with heart failure and secondary mitral regurgitation. Presented at TCT; Sept 25\u201329, San Francisco, 2019."},{"key":"2025081710351235000_8.1.e001564.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.04.034"},{"key":"2025081710351235000_8.1.e001564.23","doi-asserted-by":"crossref","unstructured":"Al-Azizi K . The COAPT trial: outcomes of transcatheter mitral valve repair in ischemic versus Non-ischemic cardiomyopathy. Presented at ACC.20\/WCC Virtual, 2020.","DOI":"10.1016\/S0735-1097(20)31805-2"},{"key":"2025081710351235000_8.1.e001564.24","doi-asserted-by":"crossref","unstructured":"Lerakis S , Kini AS , Kar S . Outcomes of transcatheter mitral valve repair in patients with secondary mitral regurgitation according to the severity of left ventricular dysfunction: the COAPT trial. Presented at ACC.20\/WCC Virtual, 2020.doi:10.1016\/S0735-1097(20)31742-3","DOI":"10.1016\/S0735-1097(20)31742-3"},{"key":"2025081710351235000_8.1.e001564.25","unstructured":"Arnold SV . Short-Term health status changes and long-term outcomes in patients with heart failure and mitral regurgitation: results from the COAPT trial. Presented at ACC.20\/WCC Virtual, 2020."},{"key":"2025081710351235000_8.1.e001564.26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(17)31600-8","article-title":"Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study","volume":"390","author":"Praz","year":"2017","journal-title":"Lancet"},{"key":"2025081710351235000_8.1.e001564.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.06.019"},{"key":"2025081710351235000_8.1.e001564.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.11.131"},{"key":"2025081710351235000_8.1.e001564.29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.21037\/acs.2018.11.04","article-title":"Transapical NeoChord mitral valve repair","volume":"7","author":"Colli","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2025081710351235000_8.1.e001564.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.090"},{"key":"2025081710351235000_8.1.e001564.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022010"},{"key":"2025081710351235000_8.1.e001564.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.062"},{"key":"2025081710351235000_8.1.e001564.33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ejcts\/ezaa256","article-title":"Safety and performance of a novel transventricular beating heart mitral valve repair system: 1-year outcomes","volume":"59","author":"Gammie","year":"2021","journal-title":"Eur J Cardiothorac Surg"}],"updated-by":[{"DOI":"10.1136\/openhrt-2020-001564corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000}}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2020-001564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:35:21Z","timestamp":1755452121000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2020-001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,28]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/openhrt-2020-001564"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2020-001564","relation":{"correction":[{"id-type":"doi","id":"10.1136\/openhrt-2020-001564corr1","asserted-by":"object"}]},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}